Navigation Links
AZOR(TM) Receives FDA Approval for Treatment of High Blood Pressure
Date:9/27/2007

ose blood pressure remains too high on currently prescribed medications."

AZOR combines the complementary actions of the powerful CCB amlodipine which inhibits the entrance of calcium into the blood vessel walls, with olmesartan medoxomil, which blocks angiotensin II receptors. Angiotensin II is a hormone that causes blood vessels to tighten and narrow. Together the two medicines relax the blood vessels so that blood can flow more easily. Benicar (olmesartan medoxomil), Daiichi Sankyo's flagship ARB product, is the fastest growing medication in the fastest growing class of blood pressure- lowering drugs.(4)

"The approval of AZOR represents an important milestone for our growing U.S. organization and underscores our continued commitment to helping more patients reach their recommended blood pressure treatment goals," said Joseph P. Pieroni, President and CEO of Daiichi Sankyo, Inc.

High blood pressure can cause permanent changes to blood vessels and the heart that may create serious problems elsewhere in the body.(5) Hypertension is one of the most prevalent conditions in the United States affecting approximately one in three American adults and approximately one billion people worldwide.(6)(7) It is often difficult to control, and of those diagnosed with high blood pressure, approximately 65 percent do not have the condition under control.(8) The number of people with high blood pressure is expected to reach about 1.6 billion worldwide by 2025.(9)

AZOR is indicated for the treatment of hypertension, alone or with other antihypertensive agents. AZOR is not indicated for the initial therapy of hypertension.

Daiichi Sankyo, Inc. and Forest Laboratories, Inc. signed a letter of intent in August to co-promote AZOR in the United States.

IMPORTANT SAFETY INFORMATION ABOUT AZOR

USE IN PREGNANCY

When used in pregnancy, during the second and third trimesters, drugs that act directly on the renin-angiotensin system can cause inju
'/>"/>

SOURCE Daiichi Sankyo, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine news :

1. Infant receives first bloodless liver transplant
2. British MPs Say Prostate Cancer Receives Low Priority in the NHS
3. Fifth US Patient Receives Artificial Heart
4. Northfield Labs Receives FDA Comments
5. Abbott Receives CE Mark Certification
6. Zactima Receives Fast Track Designation By The FDA
7. East London Receives World Class New Private Hospital Facility
8. Brinda Karat Receives Legal Notice over Ramdev Issue
9. Quake-Hit Pakistan Receives 30 Field Hospitals From Cuba
10. Medtronic’s Insulin Pump Receives Regulatory Approva
11. Aurobindo Receives Approval from USFDA for anti-AIDS drug
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2014)... new report released yesterday by the Mental Health ... mental health training and education that police personnel ... prominent issue for Canada,s police community, and today,s ... law enforcement and people with mental illnesses," says ... with an interest in the area of police ...
(Date:8/29/2014)... AURORA, Colo. (Sept. 2, 2014) A team of ... has reported the breakthrough discovery of a process to ... patients. These findings could have implications that extend beyond ... and autoimmune diseases., In an article published ... the Charles C. Gates Center for Regenerative Medicine and ...
(Date:8/29/2014)... (PRWEB) August 29, 2014 LiveOps, Inc., ... service solutions, today announced that LiveOps has been selected ... Association's (MDA) Show of Strength Telethon for the third ... raises money and awareness to support MDA’s mission to ... aggressive and sometimes fatal muscle disease. This year’s program ...
(Date:8/29/2014)... Steven Reinberg HealthDay Reporter ... The vast majority of American babies are getting the ... federal health officials said Thursday. More than 90 ... measles, mumps, and rubella (MMR); polio; hepatitis B and ... Control and Prevention. "Nationally, vaccination among children 19 ...
(Date:8/29/2014)... Pittsburgh, PA (PRWEB) August 29, 2014 ... be slippery, especially when wearing socks. Also, many patients ... ambulatory problems, poor balance, surgery recovery, Alzheimer’s, etc. Two ... in order to optimize patient safety. , This special ... medical-facility floors. It also keeps patients who are relegated ...
Breaking Medicine News(10 mins):Health News:Report advocates improved police training 2Health News:CU scientists' discovery could lead to new cancer treatment 2Health News:LiveOps Supports Muscular Dystrophy Association Show of Strength Telethon 2Health News:LiveOps Supports Muscular Dystrophy Association Show of Strength Telethon 3Health News:LiveOps Supports Muscular Dystrophy Association Show of Strength Telethon 4Health News:Most U.S. Babies Get Their Vaccines: CDC 2Health News:Most U.S. Babies Get Their Vaccines: CDC 3
... drug advertisements are appearing on television, the bulk ... companies spend annually to market their products is ... medical students. , A literature review by ... and the Regenstrief Institute, Inc. published in the ...
... study suggests it boosts production of bone-eroding cells , , MONDAY, ... by millions of diabetes patients, may contribute to bone loss, ... fear that, over the long term, Avandia (rosiglitazone) may speed ... dangerous and even fatal fractures. , The findings appear in ...
... was one of the,five deadliest storms in United ... $86 billion.) The total fatalities were estimated at ... the West Coast, CJ (of CJ,s Functional,Fitness) has ... techniques, with,old school parental inspirations, to counsel the ...
... trigger symptoms, experts warn , SATURDAY, Dec. 1 (HealthDay News) ... the season of sneezing, congestion and other woes for people ... the American Academy of Allergy, Asthma & Immunology (AAAAI). , ... they say. , "Whether it,s feasting on holiday meals, setting ...
... The third annual,Saddleback Global Summit on AIDS & The Church ... to the more than 1,700 attendees for,the Church to lead ... with HIV/AIDS need to have the invisible God made visible ... are many things we,don,t know about this epidemic, but what ...
... 30 A recent press release,incorrectly attributed findings ... out-of-pocket expenses of family caregivers. Today,SarahCare issued the ... recent press release issued by SarahCare corporate did ... taken from the "Evercare(R)/NAC,Study of Caregivers -- What ...
Cached Medicine News:Health News:Do medical schools affect the way future doctors interact with drug companies? 2Health News:Diabetes Drug Avandia Could Weaken Bones 2Health News:CJ Transforms His Functional Fitness Program Into an Additional Resource for the Hurricane Katrina Survivors 2Health News:CJ Transforms His Functional Fitness Program Into an Additional Resource for the Hurricane Katrina Survivors 3Health News:'Tis the Season For Allergy, Asthma 2Health News:Global Summit on AIDS & The Church Calls for Public, Private and Parish Sectors To Unite in Response to Worldwide Pandemic: Pastor Rick and Kay Warren Host More Than 1,700 at Event Featuring International Dignitaries, Political Figures and International E 2Health News:Global Summit on AIDS & The Church Calls for Public, Private and Parish Sectors To Unite in Response to Worldwide Pandemic: Pastor Rick and Kay Warren Host More Than 1,700 at Event Featuring International Dignitaries, Political Figures and International E 3
(Date:8/29/2014)... Aug. 29, 2014 Research and Markets ... Orthopedic Instrument Industry Report, 2014-2017" report to their ... and rising proportion of reimbursement for medical expenses, the ... with its scale presenting a CAGR of 19.2% during ... three product segments of orthopedic instruments in ...
(Date:8/29/2014)... According to a new ... type (SFE, Cold Pressed, Organic Solvent, & Others), and ... Fragrance, & Others) - Global Trends & Forecast ... the Amaranth Seed Oil Market with an analysis ... of value. The Amaranth Seed Oil Market size ...
(Date:8/29/2014)... SILVER SPRING, Md. , Aug. 29, 2014 /PRNewswire/ ... today that the U.S. District Court for the District ... in its favor in the company,s case against Sandoz, ... opinion, Judge Peter Sheridan ruled that U.S. ... Sandoz, Inc., and enjoined Sandoz from marketing its generic ...
Breaking Medicine Technology:China Orthopedic Instrument Industry Report, 2014-2017 2Amaranth Seed Oil Market worth $700.6 Million by 2019 2Amaranth Seed Oil Market worth $700.6 Million by 2019 3Amaranth Seed Oil Market worth $700.6 Million by 2019 4District Court Decision Received In Remodulin Patent Case 2
... Aug. 10, 2011 GNS Healthcare, Inc., (GNS) ... personalized medicine to improve human health, today announced ... Bristol-Myers Squibb Company (NYSE: BMY ) ... and biomarkers in the area of immuno-inflammation.  Utilizing ...
... Ardea Biosciences, Inc. (Nasdaq: RDEA ) announced today ... will present at the Wedbush Securities 2011 Life Sciences Management ... on Tuesday, August 16, 2011. This presentation ... Relations section of Ardea,s website at www.ardeabio.com . Please ...
Cached Medicine Technology:GNS Healthcare Announces Collaboration With Bristol-Myers Squibb 2Ardea Biosciences to Present at Wedbush Securities Life Sciences Conference 2
... Series II Power Supplies. The EPS-2000-II, ... EPS-6000-II. These high-voltage power supplies offer ... power operating modes, with automatic crossover ... current/300 watts maximum power (except for ...
... power supply, 100-120 and 220-240 V, provides ... 1-500 W. The two-line, 16-character LCD allows ... of run progress. Built-in infrared capability allows ... a built-in switch when using either electrical ...
... PowerPac Basic power supply, 100-120 ... of 10-300 V, 4-400 mA, ... contains a built-in switch when ... the appropriate power cord. Power ...
... PRODUCT SPECIFICATIONS Form: Granular, free flowing powder EEO(-m r ... Point (3%): less than or equal to 31C ... 76C Gel Strength (3%): greater than or equal to ... or equal to 1000 gm/cm 2 Moisture: less ...
Medicine Products: